Henrik J. Johansson

Science for Life Laboratory — Sweden

Medicine · Health Sciences

39h-index8.4kcitations154works6.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic and Hepatic Oncology Research(24), RNA Interference and Gene Delivery(21), Advanced biosensing and bioanalysis techniques(14), Advanced Proteomics Techniques and Applications(11), Parallel Computing and Optimization Techniques(10)

Publications154 total

RNA-Seq Can Be Used to Quantify Gene Expression Levels for Use in the GARDskin Assay
Toxics·2025Open Access
Abstract P4-01-30: Proteogenomic profiles of HER2-positive breast cancer and response to neoadjuvant anti-HER2 treatment
Clinical Cancer Research·2025
Mechanical control of breast cancer malignancy by promotion of mevalonate pathway enzyme synthesis
Matrix Biology·2025· 3 citedOpen Access
The DNA methylation landscape of primary triple-negative breast cancer
Nature Communications·2025· 17 citedOpen Access
Conflating the Operational Definition of Osteoporosis with Intervention Thresholds
Calcified Tissue International·2025· 3 citedOpen Access
Molecular Profiling Defines Three Subtypes of Synovial Sarcoma
Advanced Science·2024· 5 citedOpen Access
Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer
Nature Communications·2024· 22 citedOpen Access
SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma
Blood·2024· 11 citedOpen Access
SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma.
PubMed·2024
Animated lightning bolt generation using machine learning
2023· 1 citedOpen Access
FBXL12 degrades FANCD2 to regulate replication recovery and promote cancer cell survival under conditions of replication stress
Molecular Cell·2023· 14 citedOpen Access
Data from Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome
2023Open Access
Supplementary Methods SM1 from Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome
2023Open Access
Table S1 from Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome
2023Open Access
Supplementary Methods SM1 from Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome
2023Open Access
Table S10A and S10B from Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome
2023Open Access
Table S10A and S10B from Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome
2023Open Access
Table S3 from Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome
2023Open Access
Table S4 from Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome
2023Open Access
Table S3 from Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Janne Lehtiö(33), Samir EL Andaloussi(20), Ülo Langel(12), Matthew J. A. Wood(7), Tina Holm(7), Rui M. Branca(6), Jenny Forshed(6), Imre Mäger(5), Yi Lee(5), Joel Z. Nordin(5), Oscar P. B. Wiklander(5), Lukas M. Orre(5), Smith Rjh(4), Pontus Lundberg(4), Peter Guterstam(4), Pieter Vader(3), Mattias Vesterlund(3), Oscar E. Simonson(3), Mikael Huss(3), Yafeng Zhu(3)